Related Experiment Video
Updated: May 3, 2026

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Polycystin-1: a master regulator of intersecting cystic pathways
Sorin V Fedeles1, Anna-Rachel Gallagher1, Stefan Somlo2
1Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.
Autosomal dominant polycystic kidney disease (ADPKD) cyst growth is regulated by polycystin-1 (PC1), not an on-off process. Altering PC1 function can speed up or slow down cyst development in polycystic diseases.
Area of Science:
- Nephrology
- Genetics
- Molecular Biology
Background:
- Autosomal dominant polycystic kidney disease (ADPKD) is a common, lethal monogenic disorder affecting over 12 million people globally.
- The disease is caused by mutations in PKD1 or PKD2, encoding polycystin-1 (PC1) and polycystin-2 (PC2), respectively.
- PC1's role in regulating disease severity across ADPKD, ARPKD, and ADPLD is increasingly recognized.
Purpose of the Study:
- To review recent findings on polycystin-1's role in regulating cystogenesis in polycystic kidney and liver diseases.
- To highlight the translational implications of these findings for managing polycystic diseases.
- To reframe the understanding of cyst formation as a regulated process rather than a simple 'on-off' switch.
Main Methods:
- Review of recent scientific literature on polycystic diseases.
- Analysis of studies investigating the function of polycystin-1 (PC1) in cyst development.
- Synthesis of data on the modulation of cyst growth rates by PC1 functional alterations.
Main Results:
- Cyst growth rate in polycystic diseases is a regulated trait, influenced by functional polycystin-1 (PC1).
- Alterations in PC1 can accelerate or decelerate cyst development, challenging the 'on-off' model of cyst formation.
- These findings have significant implications for understanding disease progression and developing therapeutic strategies.
Conclusions:
- Polycystin-1 (PC1) plays a crucial role in modulating the severity of cystic phenotypes in ADPKD, ARPKD, and ADPLD.
- The understanding of cyst formation as a regulated process opens new avenues for therapeutic interventions in polycystic diseases.
- Further research into PC1 function is essential for advancing the clinical management of these conditions.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Master Transcription Regulators
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Positive Regulator Molecules
Positive Regulator Molecules
Hedgehog Signaling Pathway

